stockrow
Friday 6 November 2026
Export CTMX’s income statement to Excel — free account
CytomX Therapeutics, Inc.
CTMX Healthcare Biotechnology
CytomX Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $76.2 million, down 44.8% from fiscal 2024.
- Revenue
- −71.7%
- EPS
- 0.00%
- Free cash flow
- +204.1%
Quarter to September 2026, against a year earlier
2.19
0.05
+2.34%
Follow CTMX
Alert me
CytomX Therapeutics, Inc. (CTMX) P/E ratio
CytomX Therapeutics, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 25.7× (May 2024) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 0.0× | — |
| FY2024 | 2.7× | — |
| FY2023 | 0.0× | — |
| FY2022 | 0.0× | — |
| FY2021 | 0.0× | — |
| FY2020 | 0.0× | — |
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 0.0× | — |
| Jun 2026 | 0.0× | — |
| Mar 2026 | 0.0× | — |
| Dec 2025 | 0.0× | — |
| 43 more quarters | Free account |
Against its own ten years
Low 0.0×
High 25.7×
Ten-year median
0.0×
Current reading's percentile
84
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| MNPR Monopar Therapeutics Inc. compare | n/m |
| INDP Indaptus Therapeutics, Inc. compare | n/m |
| STTK Shattuck Labs, Inc. compare | n/m |
| CBIO Crescent Biopharma, Inc. compare | n/m |
| DMAC DiaMedica Therapeutics, Inc. compare | n/m |
| RGNX REGENXBIO Inc. compare | n/m |
| CTMX CytomX Therapeutics, Inc. | n/m |
| MDXG MiMedx Group, Inc compare | n/m |
| ETRA Electra Therapeutics Inc. compare | — |
| Biotechnology industry median | 10.6× |
| Healthcare sector median | 24.5× |
| Market median | 17.8× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)